Non-Invasive Prenatal Testing (NIPT) in Al Ain

Non-Invasive Prenatal Testing (NIPT) in Al Ain is available at the Mediclinic Al Jowhara Hospital MFM Unit from 10 completed weeks. It is a maternal blood screening test for trisomies 21, 18, and 13. Performance varies by condition, laboratory, and population; a high-risk result requires diagnostic confirmation.

Who This Page is For

Customized clinical pathways and insights to support our patients and referring medical partners.

Pregnant Patient

Expectant mothers from 10 completed weeks seeking screening for common chromosomal conditions without an invasive procedure.

Referring Doctor

Obstetricians seeking reliable risk stratification for chromosomal aneuploidies using cell-free DNA (cfDNA).

Abnormal Screening

Mothers with an increased-chance or inconclusive screening result who need counselling about cfDNA screening and diagnostic options.

Second Opinion

Parents wanting to discuss screening accuracy, options, and abnormal results with MFM experts.

When to see MFM

Available to all pregnant patients from 10 completed weeks after counselling about the available screening and diagnostic options.
Mothers wishing to screen for common trisomies using a maternal blood sample.
Borderline or elevated risk results on first-trimester combined screening.
Family history of chromosomal abnormalities.

What we do

Pre-test clinical counseling to explain testing limitations and capabilities.
Maternal venipuncture blood draw performed starting from 10 completed weeks.
Next-Generation Sequencing (NGS) analysis of cell-free fetal DNA.
Post-test consultation to discuss results and direct diagnostic pathways if high-risk.

What happens during the visit

1

Consultation with the MFM specialist to review gestational age and indicators.

2

A simple maternal blood draw.

3

Laboratory processing; the expected turnaround depends on the test and laboratory and is confirmed when the sample is taken.

4

Review of results with the clinical team, in-person or via telehealth.

When urgent referral is needed

  • High-risk NIPT result indicating Down, Edwards, or Patau syndrome requires prompt MFM consultation for diagnostic options.
  • NIPT cannot replace diagnostic tests; positive results must be confirmed.

Where the service is available

Available at Mediclinic Al Jowhara Hospital in Al Ain. Certain complex procedures are referred to our Abu Dhabi hub, with local pre-op and post-op care in Al Ain.

Why Fetus.ae / Mediclinic MFM

Fully integrated pre- and post-test counseling by fellowship-trained MFM specialists.
Access to CVS or amniocentesis when diagnostic confirmation is clinically appropriate, after individual counselling.
Clinical genetics laboratory partners selected for the test required.
Comprehensive ultrasound scan performed at the time of blood draw to verify viability and dating.

Mediclinic Al Jowhara Hospital

Appointments & Inquiries

800 2000

Clinical Working Hours

Clinic times vary by location and consultant. Please confirm when booking via 800 2000.

Specialists Available

Fellowship-trained, internationally recognized consultants offering evidence-based precision care.

Dr. Ali Al-Ibrahim

Dr. Ali Al-Ibrahim

Head of Unit, Consultant Maternal Fetal Medicine

Consultant in Maternal-Fetal Medicine in Al Ain and Abu Dhabi with more than 25 years of experience, University of Toronto fellowship training, and Arab and Saudi Board certification in OBGYN.

View Full Profile
Dr. Najwa Mohamed El Fky

Dr. Najwa Mohamed El Fky

Consultant Obstetrics & Gynaecology, Maternal Fetal Medicine Specialist

Consultant Obstetrician and Gynaecologist and Maternal-Fetal Medicine Specialist with extensive experience in high-risk obstetrics, prenatal diagnosis, and obstetric ultrasound.

View Full Profile

Frequently Asked Questions

Clinical answers directly from our specialists to help prepare you for your appointment.

It screens for the most common chromosomal trisomies: Trisomy 21 (Down syndrome), Trisomy 18 (Edwards syndrome), and Trisomy 13 (Patau syndrome), as well as sex chromosome variations.

NIPT uses a standard maternal blood sample and does not involve entering the pregnancy, so it does not add the procedure-related miscarriage risk associated with invasive sampling.

For trisomy 21, many validated tests report detection above 99% in appropriate populations. Performance varies by condition and laboratory, and the positive predictive value depends on prior risk. NIPT remains screening, not diagnosis.

Yes, NIPT can determine the fetal gender with high accuracy from 10 weeks of pregnancy.

A high-risk result indicates a high probability that the baby has a chromosomal condition. It is not a definitive diagnosis and must be confirmed via CVS or amniocentesis.

A low-risk result is highly reassuring and means the chance of the screened chromosomal conditions is extremely low, though it does not rule out all genetic issues.

Getting Here & Access

In Al Ain, we are based at Mediclinic Al Jowhara Hospital, a short drive from Al Jimi, Al Towiyya, Al Muwaiji, Al Mutaredh, Hili and Al Sarooj, with convenient parking. Al Ain families receive their scans, diagnostics and routine follow-up locally; the small number of highly specialised in-utero procedures are performed at our Abu Dhabi hub (about 90 minutes via the E22/Abu Dhabi–Al Ain Road) with pre-operative and post-operative care kept close to home in Al Ain.

Insurance & Coverage

The Al Ain unit works with major UAE insurers including Daman (Thiqa and Enhanced), ADNIC, Nextcare, NAS and other networks. Because plans differ in coverage and pre-authorisation, our team verifies eligibility and secures approvals ahead of your visit. Self-pay options are available for those without applicable cover.

Areas We Serve

Al JimiAl TowiyyaAl MuwaijiAl MutaredhHiliAl SaroojAl KhabisiAl MaqamZakherAl Foah

Book a Clinical Consultation

Our Maternal Fetal Medicine specialists provide evidence-based assessment, clear counselling, and coordinated care.

Medical Content Reviewed by: Dr. Ali Al-Ibrahim (MFM Consultant)
Last updated: August 2026